Skip Ribbon Commands
Skip to main content
This is a paid advertisement. Publication of this ad does not constitute an endorsement by ASPMN®.

​​​​​​​News and Announcements​


NOW AVAILABLE

ASPMN® Joint Commission
Tool Kit

 

Click here to purchase now​



​The ASPMN​® Core Curriculum for Pain Management Nursing 3rd Edition

Click here to purchase now​​


​ ​​​​​​​

  • HHS Releases Final Report

    ​The Department of Health and Human Services today released their Final Report on Pain Management Best Practices: Updates, Gaps, Inconsistencies, and Recommendations. 

    As you know we provided comments and have participated in public meetings leading up to the release. 

    You...Read More

  • Joint Commission Revision, Effective January 1, 2018

    ​The Joint Commission has approved the following revisions for prepublication for the standards related to pain assessment and management.

    ​Click here​ for full document.
    ...Read More

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
This is a paid advertisement. Publication of this ad does not constitute an endorsement by ASPMN®.

​News and Announcements

​

​

ASPMN® Year In Review

During the annual membership business meeting in Portland, Oregon, the Board shared important accomplishments and updates from the past year. Click here​ to view the information presented at this year’s ASPMN® Society Meeting.

Click here​ to view the main conference page.

​​
​​

See All News & Announcements

​Resources​

Click here​ to visit the ASPMN®​​ Store​


ASPMN® has partnered with


ASPMN® members receive a discounted tuition rate. Click here​ for more information and curriculum details.


Did you know that ASPMN® offers three “road shows” that provide continuing education right in your backyard?

  • Advanced Pharmacology 

  • Certification Preparation

  • Geriatric

​Highly skilled Master faculty will come to your hospital or institution and deliver pre-packaged courses for your staff, each offering continuing education.​

For more information, click here​. ​​

  • Opioid Analgesic REMS Resources

    ​A Risk Evaluation and Mitigation Strategy (REMS) is a program to manage known or potential serious risks associated with a drug product and is required by the Food and Drug Administration (FDA) to...Read More

​​
See All Resources